Different regions of the estrogen receptor are required for synergistic action with the glucocorticoid and progesterone receptors
- PMID: 2586523
- PMCID: PMC363700
- DOI: 10.1128/mcb.9.12.5324-5330.1989
Different regions of the estrogen receptor are required for synergistic action with the glucocorticoid and progesterone receptors
Abstract
Estrogen and progesterone or estrogen and glucocorticoid receptors functionally cooperate in gene activation if their cognate binding sites are close to one another. These interactions have been described as synergism of action of the steroid receptors. The mechanism by which synergism is achieved is not clear, although protein-protein interaction of the receptors is one of the favorite models. In transfection experiments with receptor expression vectors and a reporter gene containing estrogen and progesterone-glucocorticoid receptor binding sites, we have examined the effects that different portions of the various receptors have on synergism. N-terminal domains of the chicken progesterone and human glucocorticoid receptors, when deleted, abolished the synergistic action of these receptors with the estrogen receptor. Deletion of the carboxy-terminal amino acids 341 to 595 of the estrogen receptor produced a mutant receptor that could not trans-activate on its own. This mutant receptor did not affect the action of the glucocorticoid receptor but functioned synergistically with the progesterone receptor. We therefore conclude that the synergistic action of the receptors for estrogen and progesterone is mechanistically different from the synergistic action of the receptors for estrogen and glucocorticoid.
Similar articles
-
Estrogen and progesterone receptor-binding sites on the chicken vitellogenin II gene: synergism of steroid hormone action.Mol Cell Biol. 1988 Dec;8(12):5323-30. doi: 10.1128/mcb.8.12.5323-5330.1988. Mol Cell Biol. 1988. PMID: 3244357 Free PMC article.
-
Up-regulation of D1A dopamine receptor gene transcription by estrogen.Mol Cell Endocrinol. 1999 Oct 25;156(1-2):151-7. doi: 10.1016/s0303-7207(99)00133-1. Mol Cell Endocrinol. 1999. PMID: 10612433
-
Progesterone and glucocorticoid receptor activation in meningiomas.Neurosurgery. 1995 Jul;37(1):92-7. doi: 10.1227/00006123-199507000-00014. Neurosurgery. 1995. PMID: 8587697
-
Steroid receptor phosphorylation: Assigning function to site-specific phosphorylation.Biofactors. 2009 Nov-Dec;35(6):528-36. doi: 10.1002/biof.66. Biofactors. 2009. PMID: 19904813 Free PMC article. Review.
-
Choosing the right partner in hormone-dependent gene regulation: Glucocorticoid and progesterone receptors crosstalk in breast cancer cells.Front Endocrinol (Lausanne). 2022 Nov 4;13:1037177. doi: 10.3389/fendo.2022.1037177. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36407312 Free PMC article. Review.
Cited by
-
Mechanism of synergistic transcriptional transactivation by the human glucocorticoid receptor.Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8283-7. doi: 10.1073/pnas.88.19.8283. Proc Natl Acad Sci U S A. 1991. PMID: 1924286 Free PMC article.
-
A critical role for chromatin in mounting a synergistic transcriptional response to GAL4-VP16.Mol Cell Biol. 1994 Aug;14(8):5175-81. doi: 10.1128/mcb.14.8.5175-5181.1994. Mol Cell Biol. 1994. PMID: 8035798 Free PMC article.
-
Combined application of 17beta-estradiol and progesterone enhance vascular endothelial growth factor and surfactant protein expression in cultured embryonic lung cells of mice.Int J Pediatr. 2009;2009:170491. doi: 10.1155/2009/170491. Epub 2009 Mar 1. Int J Pediatr. 2009. PMID: 19946415 Free PMC article.
-
An interferon signature identified by RNA-sequencing of mammary tissues varies across the estrous cycle and is predictive of metastasis-free survival.Oncotarget. 2014 Jun 30;5(12):4011-25. doi: 10.18632/oncotarget.2148. Oncotarget. 2014. PMID: 24994117 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials